Deep Vein Thrombosis (DVT) Clinical Trial
Official title:
XALIA LEA- Xarelto for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE) in Latin America, EMEA and Asia
Following the findings of the clinical trials in drug development, this global
non-interventional cohort field study will investigate rivaroxaban under clinical practice
conditions in comparison with current standard of care for patients with acute venous
thoromboembolism (VTE).
The main goal is to analyze long-term safety in the use of rivaroxaban in the treatment of
acute VTE in routine clinical practice.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02523937 -
Evaluation of Soluble Fibrin in Thrombosis Exclusion
|
||
| Terminated |
NCT03805672 -
Below Knee DVT Study
|
Phase 4 | |
| Completed |
NCT00986154 -
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
|
Phase 3 | |
| Completed |
NCT02205294 -
Osteopathic Treatment and Deep Vein Thrombosis (DVT)
|
N/A | |
| Completed |
NCT02798471 -
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
|
Phase 3 | |
| Completed |
NCT01630148 -
Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries
|
N/A | |
| Completed |
NCT02073682 -
Cancer Venous Thromboembolism (VTE)
|
Phase 3 | |
| Recruiting |
NCT06195787 -
Improving Emergency Department Testing for Deep Vein Thrombosis
|
||
| Recruiting |
NCT02342444 -
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
|
Phase 4 | |
| Completed |
NCT02744092 -
Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
|
N/A | |
| Recruiting |
NCT02156401 -
VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE
|